Advances in Type 1 Diabetes Ocular Remote Tele-Health Screening
DOI:
https://doi.org/10.17140/DROJ-3-135Keywords:
Retinopathy Type 1 Diabetes, Diabetic retinopathy Retinal screenings, Non mydriatic retinal camera, Ocular coherence tomography (OCT) OCT-AAbstract
Background: Type 1 diabetes affects approximately 3 million Americans. Subjects are on average 14-years-old at time of diagnosis. It is a systemic, chronic condition that has retinal complications. Yearly ophthalmic consultation is important to maintaining adequate ocular health. The National Institute of Health (NIH) estimates that about half of individuals affected by diabetes are not aware they have some level of retinopathy.1 The goal of community base remote screenings is to identify at risk individuals and refer them for comprehensive clinical evaluation and possible intervention. Methods: Retinal screenings were conducted in July 2016 in conjunction with annual Friends for Life convention organized by Children with Diabetes (http://www.childrenwithdiabetes. com). In total, 218 participants were included in a comprehensive retinal screening. Self-reported baseline measurements of body mass index (BMI), blood pressure (BP), visual acuity and pupil size were recorded. An auto-refractor (Canon, Tokyo, Japan) and automated puff tonometer (Canon, Tokyo, Japan) were used to note visual acuity and intraocular pressure (IOP). Imaging modalities used to assess ocular health included a spectral domain ocular coherence tomography (OCT) (Optovue, iVue, Fremont, California, USA), ocular coherence tomographyangiography (Optovue, iVue, Fremont, California, USA), and a non-mydriatic retinal camera (Canon, Tokyo, Japan). Results: Our ocular screening included 218 participants, 61%female and 39% male. Ages ranged from 4 to 73 with an average of 19±12.8 years. The average blood pressure was 111/70. HbA1C ranged from 5.1 to 13.0 with an average of 7.6±1.16. Average duration of diabetes for all subjects was 10 years. Most subjects on average had been using insulin pumps and continuous glucose monitoring devices (CGM) for 7 and 3.5 years respectively. Of the 218 subjects ten had dot hemorrhages, three had flame hemorrhages and one had intraretinal microvascular abnormalities (IRMAs) affecting at least one eye. One subject required emergency referral to medical retina while 15 were referred for anterior segment evaluation for nuclear sclerosis. Conclusions: Comprehensive remote screenings including OCT, OCT-A and non-mydriatic retinal evaluation can provide a quick, efficient way to assess ocular health in T1DM. Yearly ophthalmic consultation can help detect retinal health at an early stage and better implement lifestyle modifications to minimize further complications.
References
Cavan D. The diabetes epidemic and its implications for eye health. Community Eye Health. 2015; 28(92): 61-63.
Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: The pittsburgh epidemiology of diabetes complications study cohort. diabetes. 2012; 61(11): 2987-2992. doi: 10.2337/db11-1625
Veerendranath P, Donovan L, Taneja M, et al. Measurement of consensual accommodation in vision-impaired eyes. Op-tom Vis Sci. 2014; 91(7): 752-759. doi: 10.1097/OPX.00000 00000000294
Pimentel LGM, Gracitelli CPB, da Silva LS, et al. Association between glucose levels and intraocular pressure: Pre- and post-prandial analysis in diabetic and nondiabetic patients. J Oph-thalmol. 2015; 2015: 5. doi: 10.1155/2015/832058
Helmy YM, Allah HRA. Optical coherence tomography clas-sification of diabetic cystoid macular edema. Clin Ophthalmol. 2013; 7: 1731-1737. doi: 10.2147/OPTH.S47987
Chen JT. Optical coherence tomography angiography, the powerful new imaging modality for clinical ophthalmology. Taiwan J Ophthalmol. 2017; 7(3): 113-114. doi: 10.4103/2211- 5056.214233
Wu L MN, Padgaonkar P, Kommana S, Wu E, Szirth B, Khou-ri A. Type 1 diabetic and hypertensive retinopathy: Case presen-tation and review of literature. Diabetes Res Open J. 2015; 1(4): 113-122. doi: 10.17140/DROJ-1-118
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.